Summary: Download this webinar to learn how our RED-106 noncleavable maytansine linker-payload is well-tolerated, offering wider therapeutic windows compared to other technologies.

Summary: Learn why speed and efficiency are top priorities for companies looking to develop a clonal cell line for drug substance manufacturing.

Summary: This panel discussion highlights technical and regulatory hurdles associated with development and manufacturing steps, and strategies and solutions to facilitate development through commercialization.

Summary: This webinar describes GPEx Boost technology in detail and discusses case study comparisons.

Summary: Experts provide an update on their partnership to enable and expedite scale-up to large-scale manufacturing and how it can be applied to future vaccine development.

Summary: Biologic drug substance development and biomanufacturing is a critical step in the long, complex pathway to approval. There are many considerations to be made around...

Summary: Learn about specific case studies for neuromuscular degenerative indications, AAV technology and manufacturing, strategies for navigating the current regulatory environments.

Summary: Allogeneic T-cell therapies are moving towards having breakthrough therapies available for market launch.

Summary: Learn about Catalent’s journey into the Cell and Gene therapy space, overcoming challenges, and the company’s commitment to its partners. 

Summary: R&D execs discuss how they've reorganized global teams, tapped new programs to fight COVID-19 and plan for the future after the pandemic.